2m 2m 2m 2m 2m 2m 2m
MBX BIO (MBX)
NASDAQ
$30.05-$0.65 (-2.13%)
Price as of Jun 03, 2026 4:35 PM EDT- $1.5BMarket Cap
- 124.74%1-Year Change
- BiotechnologyIndustry
MBX BIO (MBX)
$30.05-$0.65 (-2.13%)
MBX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $30.70 | ||
Change | +$0.05 (+0.16%) | ||
Open | $30.29 | ||
High | $31.35 | ||
Low | $29.57 | ||
Previous Close | $30.65 | ||
Volume | 609,442 | ||
30-Day Average Volume | 727,979 | ||
1-Week Change | -3.31% | ||
1-Month Change | 3.09% | ||
1-Year Change | 124.74% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 47.6M | ||
Total Assets | $452.7M | ||
Market Cap | $1.5B | ||
Enterprise Value | $1.5B | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$23.5M | ||
Free Cash Flow | -$20.6M | ||
EBIT | -$23.5M | ||
EBITDA | -$23.5M | ||
Net Working Capital | $434.0M | ||
EPS | -$0.50 | ||
Enterprise Value/EBITDA | -62 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 3 | ||
P/E | -63 | ||
PEG | 37 | ||
Price/Free Cash Flow | -73 | ||
Price/Operating Cash Flow | -74 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue